THE COMPANY: The Report: Indonesia 2010 indicated that XL Axiata’s (EXCL) positive growth in the first half of 2010 would provide a clear picture of the company’s future. On the back of strategic initiatives, EXCL recorded revenue increases in 2010, which helped to improve share values. EXCL’s...
Despite a turbulent history in financial services, Indonesia has plenty to offer overseas bankers. Some of what is compelling has long been so, such as the huge potential inherent in the world’s fourth-most-populous nation. Indonesia has for decades had a significant and largely untapped customer base – only about 20% of the country’s adults have...
The local banking sector has undergone many improvements since the 1997-98 Asian financial crisis. Risks are now being more carefully managed at the regulatory and individual bank levels, with strong incentives to manage credit portfolio losses. Perhaps as a result of these changes, the ratio of non-performing loans (NPLs) has declined over the last...
Since the global financial crisis hit in late 2007, portfolio investors worldwide have cast a wider net, looking for capital gains in a world where economic growth is far from certain. In their search for markets that have shown resilience, many have turned to the countries of South-east Asia.
THE COMPANY: In line with expectations, Kalbe Farma (KLBF) reported increased earnings in the first half of 2011. Sales grew approximately 5.14% year-on-year (y-o-y) to Rp4.94trn ($592.8m). This figure is equal to around 44.07% of the full-year projection of Rp11.22trn ($2.38bn). Pharmaceutical packaging...
With GDP growth at 6.1% in 2010 and forecast to reach 6.6% in 2011, on the back of buoyant consumption, expectations are high for insurance in Indonesia.
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×